Study #2020-1150
Outcomes after Chimeric Antigen Receptor Therapy (CAR-T), and/or Bispecific Therapy and Radiation Therapy (RT) for Hematologic Malignancies
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study collects information on outcomes after chimeric antigen receptor therapy and radiation therapy for hematologic malignancies. Collecting information from patients before, during, and after receiving chimeric antigen receptor therapy or radiation therapy may help doctors to optimize patient selection, dose, timing, and sequencing of these treatments.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hematopoietic and Lymphoid Cell Neoplasm
Study phase:
Physician name:
Penny Fang
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.